List ViewBy sflwa / April 21, 2022 Search Entries: Clear Displaying 2,001 - 2,025 of 2,995 « 1 … 79 80 81 82 83 … 120 » NRG1 as Target in NSCLC? Click here for download. PARP Inhibitors in SCLC Click here for download. Predictive Biomarkers for SCLC Click here for download. Optimal Management of Limited Stage SCLC Click here for download. Optimal Management of Extensive SCLC (1st and 2nd Line) Click here for download. Brain Radiotherapy in SCLC: When? Click here for download. HER-3 as a New Target in NSCLC Click here for download. Building the Case for HER-2 Inhibitors in NSCLC Click here for download. TROP-2 and AXL as Targets in NSCLC Click here for download. Targeting CEACAM5 and ROR1/ROR2 in NSCLC Click here for download. Updates in Bispecific Antibodies in NSCLC Click here for download. CAR-T Cell in NSCLC: Is it Feasible? Click here for download. The Importance of TIME in Cancer Fight: How to Target It? Click here for download. Role of Interleukins in TIME to Improve Immunotherapy Efficacy Click here for download. The New Role of Microbiome in Lung Cancer Immunotherapy Click here for download. Overcoming T-Cell Exhaustion Click here for download. Role of Radiotherapy in TIME: Good? Bad? Don’t know? Click here for download. The Role of Co-Mutations with Immunotherapy Response in NSCLC Click here for download. Developing New Anti-CTL4s for NSCLC: Is There Any Role? Click here for download. Frontline: What are We Adding to Checkpoint Inhibitors and Chemotherapy? Click here for download. What Comes After Immunotherapy Failure in Terms of More Immunomodulation (Anti-Angiogenic Agents, IL-15, OX-40 and Others)? Click here for download. Optimal Surgical Approach for Mesothelioma Click here for download. Radiation Induced Immune-Response in NSCLC Click here for download. Systemic Therapies for Mesothelioma Click here for download. Novel Therapies for Thymic Malignancies Click here for download.
